Information for "Clopidogrel dosing and role of genetics: ELEVATE-TIMI 56 trial"
Jump to navigation
Jump to search
Basic information
| Display title | Clopidogrel dosing and role of genetics: ELEVATE-TIMI 56 trial |
| Default sort key | Clopidogrel dosing and role of genetics: ELEVATE-TIMI 56 trial |
| Page length (in bytes) | 2,538 |
| Namespace ID | 0 |
| Page ID | 186071 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Priyamvada Singh (talk | contribs) |
| Date of page creation | 14:39, 25 November 2011 |
| Latest editor | WikiBot (talk | contribs) |
| Date of latest edit | 13:36, 2 November 2012 |
| Total number of edits | 10 |
| Total number of distinct authors | 2 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |